A detailed history of Zwj Investment Counsel Inc transactions in Amgen Inc stock. As of the latest transaction made, Zwj Investment Counsel Inc holds 7,764 shares of AMGN stock, worth $2.49 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,764
Previous 7,502 3.49%
Holding current value
$2.49 Million
Previous $2.13 Million 13.74%
% of portfolio
0.11%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$262.75 - $319.31 $68,840 - $83,659
262 Added 3.49%
7,764 $2.43 Million
Q1 2024

Apr 26, 2024

SELL
$268.87 - $324.56 $44,363 - $53,552
-165 Reduced 2.15%
7,502 $2.13 Million
Q4 2023

Jan 31, 2024

SELL
$255.7 - $288.46 $57,532 - $64,903
-225 Reduced 2.85%
7,667 $2.21 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $1.73 Million - $2.14 Million
7,892 New
7,892 $2.12 Million
Q1 2023

Apr 26, 2023

BUY
$225.79 - $275.2 $39,061 - $47,609
173 Added 2.2%
8,022 $1.94 Million
Q4 2022

Jan 24, 2023

SELL
$229.03 - $291.01 $57,257 - $72,752
-250 Reduced 3.09%
7,849 $0
Q3 2022

Oct 19, 2022

BUY
$224.46 - $253.15 $160,713 - $181,255
716 Added 9.7%
8,099 $1.83 Million
Q2 2022

Aug 02, 2022

BUY
$230.71 - $256.74 $1.05 Million - $1.17 Million
4,572 Added 162.65%
7,383 $1.8 Million
Q4 2021

Mar 31, 2022

BUY
$198.88 - $227.6 $559,051 - $639,783
2,811 New
2,811 $632,000
Q3 2021

Mar 31, 2022

SELL
$212.27 - $248.7 $603,271 - $706,805
-2,842 Closed
0 $0
Q2 2021

Mar 31, 2022

SELL
$233.58 - $259.14 $28,029 - $31,096
-120 Reduced 4.05%
2,842 $693,000
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $17,752 - $20,688
80 Added 2.78%
2,962 $737,000
Q4 2020

Feb 26, 2021

BUY
$216.38 - $257.67 $74,218 - $88,380
343 Added 13.51%
2,882 $663,000
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $73,914 - $82,199
-315 Reduced 11.04%
2,539 $645,000
Q2 2020

Jul 28, 2020

SELL
$197.81 - $242.74 $24,330 - $29,857
-123 Reduced 4.13%
2,854 $673,000
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $23,272 - $29,913
123 Added 4.31%
2,977 $718,000
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $29,172 - $34,196
-175 Reduced 5.78%
2,854 $526,000
Q1 2019

May 21, 2019

SELL
$180.87 - $203.88 $54,984 - $61,979
-304 Reduced 9.12%
3,029 $575,000
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $100,617 - $117,453
564 Added 20.37%
3,333 $649,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $18,529 - $20,889
-100 Reduced 3.49%
2,769 $574,000
Q1 2018

Apr 24, 2018

SELL
$169.43 - $198.0 $733,293 - $856,944
-4,328 Reduced 60.14%
2,869 $489,000
Q4 2017

Feb 01, 2018

BUY
$168.79 - $188.59 $100,430 - $112,211
595 Added 9.01%
7,197 $1.25 Million
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $1.1 Million - $1.26 Million
6,602
6,602 $1.23 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Zwj Investment Counsel Inc Portfolio

Follow Zwj Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zwj Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Zwj Investment Counsel Inc with notifications on news.